Forward Pharma A/S Employee Directory
Biotechnology ResearchHovedstaden, Denmark2-10 Employees
Forward Pharma A/S was a Danish biotechnology research company focused on developing a proprietary dimethyl fumarate formulation for inflammatory and neurological indications. The firm was based in Hellerup in the Hovedstaden region of Denmark and operated with a small team. In 2017 it granted irrevocable rights to its intellectual property to Biogen, reflecting a licensing arrangement with a larger partner. The company had earlier collaborations, including a 2016 partnership with Ixchelpharma. It completed a voluntary solvent liquidation in 2025.